Gene · 5037
Papers2,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning based screening of biomarkers associated with cell death and immunosuppression of multiple life stages sepsis populations. | Sci Rep | 2025 | 40830558 | PubTator, text mining | PubMed |
| RKIP regulates bone marrow macrophage differentiation to mediate osteoclastogenesis and H-type vessel formation. | Nat Commun | 2025 | 40817102 | PubTator, text mining | PubMed |
| The role of m5C, m1A and m7G modifications in tumors of urinary system. | Front Cell Dev Biol | 2025 | 40809690 | PubTator, text mining | PubMed |
| Pan-Cancer Computational Analysis of RKIP (PEBP1) and LKB1 (STK11) Co-Expression Highlights Distinct Immunometabolic Dynamics and Therapeutic Responses Within the Tumor Microenvironment. | Int J Mol Sci | 2025 | 40806276 | PubTator, text mining | PubMed |
| Author Correction: Bmi-1 promotes the proliferation, migration and invasion, and inhibits cell apoptosis of human retinoblastoma cells via RKIP. | Sci Rep | 2025 | 40764337 | PubTator, text mining | PubMed |
| Research Progress on Glycolysis in the Pathogenesis of Asthma. | J Asthma Allergy | 2025 | 40746369 | PubTator, text mining | PubMed |
| Redox mechanism of glycerophospholipids and relevant targeted therapy in ferroptosis. | Cell Death Discov | 2025 | 40744916 | PubTator, text mining | PubMed |
| RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR-targeted therapies. | Mol Oncol | 2025 | 40720248 | PubTator, text mining | PubMed |
| Machine learning identification of key genes in cardioembolic stroke and atherosclerosis: their association with pan-cancer and immune cells. | Eur J Med Res | 2025 | 40708018 | PubTator, text mining | PubMed |
| Raf-kinase inhibitor protein (RKIP): A therapeutic target in colon cancer. | Biochim Biophys Acta Rev Cancer | 2025 | 40681057 | PubTator, text mining | PubMed |
| Identification of important biomarkers associated with ferroptosis in diabetic retinopathy via integrative bioinformatics analysis. | Exp Eye Res | 2025 | 40681034 | PubTator, text mining | PubMed |
| Genome-Wide Identification and Functional Analysis of the PEBP Gene Family in Begonia semperflorens 'Super Olympia' Reveal Its Potential Role in Regulating Flowering. | Int J Mol Sci | 2025 | 40650069 | PubTator, text mining | PubMed |
| Cellular engineering strategies for soluble and secretory recombinant human insulin production in Pseudomonas fluorescens and batch bioreactor study. | J Biotechnol | 2025 | 40513666 | PubTator, text mining | PubMed |
| PEBP1 and 15-LO-1 in Asthma: Biomarker Potential for Diagnosis and Severity Stratification. | Diagnostics (Basel) | 2025 | 40506894 | PubTator, text mining | PubMed |
| HIV-1 latency: From acquaintance to confidant. | J Virus Erad | 2025 | 40497153 | PubTator, text mining | PubMed |
| Raf kinase inhibitor protein modulator of gut microbiota and immunotherapy responses in cancer. | Biochim Biophys Acta Rev Cancer | 2025 | 40460898 | PubTator, text mining | PubMed |
| Integration of proteomics and artificial intelligence-driven OCT biomarker analysis in central retinal vein occlusion. | Exp Eye Res | 2025 | 40451318 | PubTator, text mining | PubMed |
| Beyond the trinity: unraveling a fourth clade in the PEBP gene family in plants. | Plant Cell Rep | 2025 | 40383720 | PubTator, text mining | PubMed |
| Using proteomic biomarkers to estimate acute ischaemic stroke onset time. | Commun Med (Lond) | 2025 | 40382445 | PubTator, text mining | PubMed |
| The surface protein Gbp of Fusobacterium nucleatum inhibits osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2. | J Transl Med | 2025 | 40369630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5037/papers?page=5